CommercialAdministrativeMedium impact
[Virginia] Lenalidomide is now available with end‑to‑end REMS support
Anthem BCBS·VA · Oncology, Hematology·Provider Bulletin
Effective date
May 1, 2026
We identified it
May 3, 2026
Summary
Lenalidomide is now available through BioPlus Specialty Pharmacy with end-to-end REMS (Risk Evaluation and Mitigation Strategies) support for Virginia commercial plans. BioPlus manages the complete REMS process, reduces administrative burden, and streamlines therapy initiation with a single point of contact and expedited patient enrollment.
Action Required
Effective May 1, 2026: Providers prescribing lenalidomide in Virginia must route all prescriptions and REMS management through BioPlus Specialty Pharmacy (NCPDP 1078535, Fax: 800-269-5493). Update provider workflows and EMR templates to direct staff to contact BioPlus for lenalidomide therapy initiation and REMS documentation. Providers should reference bioplusrx.com and utilize Availity Chat with Payer during business hours for eligibility, authorization, and claims support. Update internal protocols to recognize BioPlus as the mandatory specialty pharmacy vendor for lenalidomide to avoid claim denials and ensure compliant REMS processing.